Seeking Alpha

BCRX
  BioCryst Pharmaceuticals, Inc. - NASDAQ

11/26/2014, 8:47 PM ET
52wk high:  
52wk low:  
EPS:  
PE (ttm):  
Div Rate:  
Yield:  
Market Cap:  
Volume:  
BCRX vs. ETF Alternatives
Company Description
Biocryst Pharmaceuticals Inc. is engaged in the design, optimization and development of novel drugs that block key enzymes involved in the pathogenesis of diseases. Its drug candidates include Peramivir, BCX4161, Forodesine and Ulodesine, among others.
Sector: Healthcare
Industry: Biotechnology
Country: United States